🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Turkey / NCT07616804
Starting soon Not applicable

Cognitive Responses to Acute Breath-Hold Diving Training in Female Divers

NCT07616804 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-01
Last updated
2026-06-01

Condition(s) studied

Sport PhysiologyCognitive Performance

Investigational drug(s) / intervention(s)

Land-Based Breath-Hold TrainingWater-Based Breath-Hold TrainingControl Session

Land-Based Breath-Hold Training: Participants will perform structured land-based breath-hold exercises consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.

Water-Based Breath-Hold Training: Participants will perform structured breath-hold exercises in a swimming pool environment consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.

Control Session: Participants will undergo baseline cognitive, respiratory, mood, and physiological assessments without structured apnea or breath-hold exercise intervention.

Study summary

This study aims to investigate the acute cognitive and physiological responses to breath-hold diving training in trained female divers. Participants will complete three separate sessions including a control session, a land-based breath-hold training session, and a water-based breath-hold training session in randomized order. Cognitive performance, mood state, heart rate responses, respiratory function, and maximal breath-hold capacity will be evaluated before and after the interventions. The study is expected to improve understanding of how acute apnea-based diving exercises influence cognitive functions and physiological adaptations under different environmental conditions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Licensed breath-hold or free-diving athletes * Aged between 18 and 30 years * Minimum of 5 years of training experience * No known cardiovascular or pulmonary disease * Non-smokers * Willing to participate voluntarily * Refraining from intense exercise within 24 hours before testing Exclusion Criteria: * Use of performance-enhancing drugs or ergogenic aids * Presence of chronic sports injury * Alcohol consumption within 24 hours before testing * Caffeine intake within 2 hours before testing * Sleep deprivation or severe fatigue * Current medication use Fear of water or inability to complete breath-hold procedures

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Gelisim University Istanbul Turkey (Türkiye)

More Istanbul Gelisim University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07616804 on ClinicalTrials.gov ↗ ← All trials in Turkey